Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study

SciTech Development, LLC, an early-stage clinical pharmaceutical firm, effectively navigated funding constraints by conducting their Phase 1 study for non-Hodgkin lymphoma without a third-party CRO. They employed CRIO's integrated eSource-EDC solution to streamline data capture and management. This innovative approach not only reduced overhead and monitoring expenses but also saved several hundred thousand dollars, thereby extending their financial runway. The user-friendly platform facilitated efficient data capture and management across multiple academic medical centers, enabling remote Source Data Review and Verification. This strategic use of CRIO's system allowed SciTech to rapidly access trial data, adapt strategies promptly, and manage their clinical trial operations effectively despite budgetary limitations.